COMBINED PHARMACEUTICAL PREPARATION FOR TREATMENT OF HUMAN TUMOUR CELLS, USE OF O6-BENZYLGUANINE AND TEMOZOLOMIDE FOR ITS PRODUCTION AND PHARMACEUTICAL KITE
Kombinovaný farmaceutický prostriedok na simultánne, oddelené alebo postupné použitie na liečbu ľudských nádorových buniek obsahuje účinné množstvo O6-benzylguanínu a účinné množstvo temozolomidu s jedným alebo viacerými farmaceuticky prijateľnými nosičmi. Je opísané aj použitie O6-benzylguanínu a t...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; slo |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BAER JOHN COLIN WATSON AMANDA JEAN MARGISON GEOFFREY PAUL NEWLANDS EDWARD STUART RAFFERTY JOSEPH ANTHONY FREEMAN AZADEH ALISON |
| description | Kombinovaný farmaceutický prostriedok na simultánne, oddelené alebo postupné použitie na liečbu ľudských nádorových buniek obsahuje účinné množstvo O6-benzylguanínu a účinné množstvo temozolomidu s jedným alebo viacerými farmaceuticky prijateľnými nosičmi. Je opísané aj použitie O6-benzylguanínu a temozolomidu na prípravu farmaceutického prostriedku na liečbu ľudských nádorových buniek a farmaceutický kit, ktorý obsahuje oddelene farmaceutický prostriedok temezolomid a oddelene farmaceutický prostriedok O6-benzylguanín.ŕ
The toxicity of temozolomide, an anti-tumour agent useful in the treatment of various mammalian neoplasms, can be potentiated by the prior administration of an ATase inhibiting agent, i.e., O -benzylguanine. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SK282452BB6</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SK282452BB6</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SK282452BB63</originalsourceid><addsrcrecordid>eNqNjTsOwjAQBdNQIOAOewDShI9oN86GWNjeyFkX0KAImQpBpHAcDkuCqKioXvFGM9Pkpdjm2lEBdYXeoqIgWqGB2lONHkWzg5I9iCcUS06AS6iCRQcSLAcPioxplhAaGi_epjm509HsA7pBDOgKELJ8YsNWF_SxaWmGAhdBfQIj89M_aKF5Mrm2tz4uvjtLoCRRVRq7xzn2XXuJ9_g8N4dsl603WZ5vV38gbwhgQ9M</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMBINED PHARMACEUTICAL PREPARATION FOR TREATMENT OF HUMAN TUMOUR CELLS, USE OF O6-BENZYLGUANINE AND TEMOZOLOMIDE FOR ITS PRODUCTION AND PHARMACEUTICAL KITE</title><source>esp@cenet</source><creator>BAER JOHN COLIN ; WATSON AMANDA JEAN ; MARGISON GEOFFREY PAUL ; NEWLANDS EDWARD STUART ; RAFFERTY JOSEPH ANTHONY ; FREEMAN AZADEH ALISON</creator><creatorcontrib>BAER JOHN COLIN ; WATSON AMANDA JEAN ; MARGISON GEOFFREY PAUL ; NEWLANDS EDWARD STUART ; RAFFERTY JOSEPH ANTHONY ; FREEMAN AZADEH ALISON</creatorcontrib><description>Kombinovaný farmaceutický prostriedok na simultánne, oddelené alebo postupné použitie na liečbu ľudských nádorových buniek obsahuje účinné množstvo O6-benzylguanínu a účinné množstvo temozolomidu s jedným alebo viacerými farmaceuticky prijateľnými nosičmi. Je opísané aj použitie O6-benzylguanínu a temozolomidu na prípravu farmaceutického prostriedku na liečbu ľudských nádorových buniek a farmaceutický kit, ktorý obsahuje oddelene farmaceutický prostriedok temezolomid a oddelene farmaceutický prostriedok O6-benzylguanín.ŕ
The toxicity of temozolomide, an anti-tumour agent useful in the treatment of various mammalian neoplasms, can be potentiated by the prior administration of an ATase inhibiting agent, i.e., O -benzylguanine.</description><edition>7</edition><language>eng ; slo</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2002</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020205&DB=EPODOC&CC=SK&NR=282452B6$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020205&DB=EPODOC&CC=SK&NR=282452B6$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BAER JOHN COLIN</creatorcontrib><creatorcontrib>WATSON AMANDA JEAN</creatorcontrib><creatorcontrib>MARGISON GEOFFREY PAUL</creatorcontrib><creatorcontrib>NEWLANDS EDWARD STUART</creatorcontrib><creatorcontrib>RAFFERTY JOSEPH ANTHONY</creatorcontrib><creatorcontrib>FREEMAN AZADEH ALISON</creatorcontrib><title>COMBINED PHARMACEUTICAL PREPARATION FOR TREATMENT OF HUMAN TUMOUR CELLS, USE OF O6-BENZYLGUANINE AND TEMOZOLOMIDE FOR ITS PRODUCTION AND PHARMACEUTICAL KITE</title><description>Kombinovaný farmaceutický prostriedok na simultánne, oddelené alebo postupné použitie na liečbu ľudských nádorových buniek obsahuje účinné množstvo O6-benzylguanínu a účinné množstvo temozolomidu s jedným alebo viacerými farmaceuticky prijateľnými nosičmi. Je opísané aj použitie O6-benzylguanínu a temozolomidu na prípravu farmaceutického prostriedku na liečbu ľudských nádorových buniek a farmaceutický kit, ktorý obsahuje oddelene farmaceutický prostriedok temezolomid a oddelene farmaceutický prostriedok O6-benzylguanín.ŕ
The toxicity of temozolomide, an anti-tumour agent useful in the treatment of various mammalian neoplasms, can be potentiated by the prior administration of an ATase inhibiting agent, i.e., O -benzylguanine.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2002</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjTsOwjAQBdNQIOAOewDShI9oN86GWNjeyFkX0KAImQpBpHAcDkuCqKioXvFGM9Pkpdjm2lEBdYXeoqIgWqGB2lONHkWzg5I9iCcUS06AS6iCRQcSLAcPioxplhAaGi_epjm509HsA7pBDOgKELJ8YsNWF_SxaWmGAhdBfQIj89M_aKF5Mrm2tz4uvjtLoCRRVRq7xzn2XXuJ9_g8N4dsl603WZ5vV38gbwhgQ9M</recordid><startdate>20020205</startdate><enddate>20020205</enddate><creator>BAER JOHN COLIN</creator><creator>WATSON AMANDA JEAN</creator><creator>MARGISON GEOFFREY PAUL</creator><creator>NEWLANDS EDWARD STUART</creator><creator>RAFFERTY JOSEPH ANTHONY</creator><creator>FREEMAN AZADEH ALISON</creator><scope>EVB</scope></search><sort><creationdate>20020205</creationdate><title>COMBINED PHARMACEUTICAL PREPARATION FOR TREATMENT OF HUMAN TUMOUR CELLS, USE OF O6-BENZYLGUANINE AND TEMOZOLOMIDE FOR ITS PRODUCTION AND PHARMACEUTICAL KITE</title><author>BAER JOHN COLIN ; WATSON AMANDA JEAN ; MARGISON GEOFFREY PAUL ; NEWLANDS EDWARD STUART ; RAFFERTY JOSEPH ANTHONY ; FREEMAN AZADEH ALISON</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SK282452BB63</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; slo</language><creationdate>2002</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BAER JOHN COLIN</creatorcontrib><creatorcontrib>WATSON AMANDA JEAN</creatorcontrib><creatorcontrib>MARGISON GEOFFREY PAUL</creatorcontrib><creatorcontrib>NEWLANDS EDWARD STUART</creatorcontrib><creatorcontrib>RAFFERTY JOSEPH ANTHONY</creatorcontrib><creatorcontrib>FREEMAN AZADEH ALISON</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BAER JOHN COLIN</au><au>WATSON AMANDA JEAN</au><au>MARGISON GEOFFREY PAUL</au><au>NEWLANDS EDWARD STUART</au><au>RAFFERTY JOSEPH ANTHONY</au><au>FREEMAN AZADEH ALISON</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMBINED PHARMACEUTICAL PREPARATION FOR TREATMENT OF HUMAN TUMOUR CELLS, USE OF O6-BENZYLGUANINE AND TEMOZOLOMIDE FOR ITS PRODUCTION AND PHARMACEUTICAL KITE</title><date>2002-02-05</date><risdate>2002</risdate><abstract>Kombinovaný farmaceutický prostriedok na simultánne, oddelené alebo postupné použitie na liečbu ľudských nádorových buniek obsahuje účinné množstvo O6-benzylguanínu a účinné množstvo temozolomidu s jedným alebo viacerými farmaceuticky prijateľnými nosičmi. Je opísané aj použitie O6-benzylguanínu a temozolomidu na prípravu farmaceutického prostriedku na liečbu ľudských nádorových buniek a farmaceutický kit, ktorý obsahuje oddelene farmaceutický prostriedok temezolomid a oddelene farmaceutický prostriedok O6-benzylguanín.ŕ
The toxicity of temozolomide, an anti-tumour agent useful in the treatment of various mammalian neoplasms, can be potentiated by the prior administration of an ATase inhibiting agent, i.e., O -benzylguanine.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; slo |
| recordid | cdi_epo_espacenet_SK282452BB6 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | COMBINED PHARMACEUTICAL PREPARATION FOR TREATMENT OF HUMAN TUMOUR CELLS, USE OF O6-BENZYLGUANINE AND TEMOZOLOMIDE FOR ITS PRODUCTION AND PHARMACEUTICAL KITE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T17%3A55%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BAER%20JOHN%20COLIN&rft.date=2002-02-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESK282452BB6%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |